Xu K et al. |
A highly anti-selective asymmetric Henry reaction catalyzed by a chiral copper complex: applications to the syntheses of (+)-spisulosine and a pyrroloisoquinoline derivative. |
2012 |
Chemistry |
pmid:22907874
|
Massard C et al. |
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors. |
2012 |
Invest New Drugs |
pmid:22215532
|
Vilar E et al. |
A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors. |
2012 |
Invest New Drugs |
pmid:20820909
|
Chen BS et al. |
Diastereoselective synthesis and bioactivity of long-chain anti-2-amino-3-alkanols. |
2011 |
Eur J Med Chem |
pmid:21955681
|
Garofalo K et al. |
Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. |
2011 |
J. Clin. Invest. |
pmid:22045570
|
Scherer SS |
The debut of a rational treatment for an inherited neuropathy? |
2011 |
J. Clin. Invest. |
pmid:22045569
|
Rotthier A et al. |
Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I. |
2011 |
Hum. Mutat. |
pmid:21618344
|
Merrill AH |
Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. |
2011 |
Chem. Rev. |
pmid:21942574
|
Schöffski P et al. |
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies. |
2011 |
Cancer Chemother. Pharmacol. |
pmid:21465314
|
Malik G et al. |
Aziridines from intramolecular alkene aziridination of sulfamates: reactivity toward carbon nucleophiles. application to the synthesis of spisulosine and its fluoro analogue. |
2011 |
J. Org. Chem. |
pmid:21812488
|